Medpace (NASDAQ:MEDP) was downgraded by analysts at Zacks Research from a "strong-buy" rating to a "hold" rating.
Medpace (NASDAQ:MEDP) was given a new $660.00 price target on by analysts at Mizuho.
Medpace (MEDP) Stock Dips While Market Gains: Key Facts [Yahoo! Finance]
Assessing Medpace Holdings (MEDP) Valuation After Strong 1-Year Gains And Recent Pullback [Yahoo! Finance]
CCMP Growth Appoints Managing Director Patrick McGrath to Its Investment Committee and Makes Four Additional Firmwide Promotions [Yahoo! Finance]